Abstract
This Outcome Studies Software suite has been designed and carried out by Surgeons for Surgeons in order to provide the Orthopaedic Community with a valuable tool devoted to the computerized clinical follow-up of Joint Arthroplasty, named OrthoWave(tm). The development of the OrthoWave(tm) suite, since 1996, has got involved clinical studies coordinators, software engineers, orthopaedic surgeons, and statisticians.
One underlying theme regarding Health Care has and always will be constant: the need to understand if our treatments actually work. Providing answers makes not only scientific sense but pragmatic and economic sense as well. In such a way, Evaluation in Joint Arthroplasty has become a master word in the realm of Orthopaedic Surgery, which thus gets many actors involved, be they Surgeons, Scientific Societies, Health Department Authorities, Journal Editors, and Orthopaedic Devices Manufacturer.
While bearing in mind that more than a million of Hip and Knee replacements are worldly performed annually and there are thousands of devices and device combinations in use to achieve arthroplasties, these replacement procedures have to be properly evaluated as a very challenging procedure. An outcomes study software needs to allow for easy and user friendly collection of clinical data and related images, while preserving privacy of patients and their personal data. This software must then provide consistent statistical and survivorship analyzes in the very long run. The OrthoWave(tm) software has been widely used worldly, and currently features the on-line Version 6, now available as a web-based secured “cloud computing” computer system. The so called “regular databases” can be linked to additional “scientific databases” and “monitored databases” able to set up together a very consistent and efficient global system.
Roughly speaking, OrthoWave addresses (1) data collection of Surgeons themselves, able to self evaluate their surgeries while owning their own data, (2) Local Registries, involving groups of Surgeons, to analyze, report and publish clinical series in the Literature, (3) Brand Registries, for tracking upon large multicenter studies at an early stage any problem that might occur with any given implant, (4) Clinical Affairs Departments in Industry, (5) and finally enables potential automatic links to National and International Joint Registries.
This OrthoWave software has thus permitted a “fine tuning” of clinical results, radiographic findings, survival rates and real assessment of quality of life, helping to determine in large databases studies if implant composition or joint replacement features can be associated with decreased need for repeat surgery, and to outline best methodological approaches to the assessment of failures in arthroplasty, in terms of functioning, quality of life and long-term disability.
All along these 14 years of continuous use of this OrthoWave software suite, we have tried to help it to be more and more efficient and user friendly. The current on-line web-based version now meets our expectation, and is flexible enough to adapt itself to future needs and better treatments for patients.
